Senior Independent Director
Appointed: July 1, 2015
Committee membership: Remuneration Committee and Nomination & Governance Committee
Olivier served as Non-Executive Director prior to his appointment as Senior Independent Non-Executive Director on 24 April, 2018.
Skills & experience: Olivier brings to the Board his extensive international business and leadership experience gained through roles held in pharmaceutical and healthcare companies across Europe, the Middle East and the U.S. He previously served as Chief Executive Officer at Smith & Nephew plc, and Chief Executive Officer and President of Pierre Fabre Group and as President of Abbott Pharmaceuticals; a division of U.S.-based Abbott Laboratories. Olivier also held diverse commercial leadership positions at GlaxoSmithKline and its predecessor companies in France. He holds an MBA from HEC Paris School of Management and a doctorate in Pharmacy from the University of Paris.
Key appointments: Biotech Promise (Non-Executive Director), Smiths Group plc (Non-Executive Director), LEO Pharma (Vice Chairman) and Virbac SA (Non-Executive Director).